LifeMD
LFMD
104 hedge funds and large institutions have $64.7M invested in LifeMD in 2025 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 34 increasing their positions, 32 reducing their positions, and 30 closing their positions.
36% more call options, than puts
Call options by funds: $1.24M | Put options by funds: $912K
6% more repeat investments, than reductions
Existing positions increased: 34 | Existing positions reduced: 32
3.77% less ownership
Funds ownership: 43.17% → 39.4% (-3.8%)
9% less funds holding
Funds holding: 114 → 104 (-10)
33% less first-time investments, than exits
New positions opened: 20 | Existing positions closed: 30
53% less capital invested
Capital invested by funds: $139M → $64.7M (-$74.3M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$3.5M |
| 2 |
PGCM
Prescott Group Capital Management
Tulsa,
Oklahoma
|
+$3.34M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
+$1.94M |
| 4 |
WCA
Whetstone Capital Advisors
Shawnee Mission,
Kansas
|
+$1.61M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$821K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
N
Nuveen
Charlotte,
North Carolina
|
-$5.94M |
| 2 |
Morgan Stanley
New York
|
-$3.15M |
| 3 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$2.1M |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$1.79M |
| 5 |
UIC
Uniplan Investment Counsel
Milwaukee,
Wisconsin
|
-$1.57M |
LFMD Hedge Fund Activity: Q4 2025 in Review
104 of the 8,223 institutional investors tracked by Wall St. Rank reported a position in LifeMD (LFMD) for Q4 2025, worth a combined $64.7M — down 53% from $139M a quarter earlier.
Sellers outnumbered buyers: 30 funds closed out of LFMD and 20 opened new positions — a net loss of 10 holders — while 32 trimmed existing stakes and 34 added.
The largest buyer was Federated Hermes, adding an estimated $3.5M. The largest seller was Nuveen, cutting an estimated $5.94M.
- 104 institutional investors held LifeMD (LFMD) as of Q4 2025, down from 114 in Q3 2025.
- Funds reported $64.7M of LifeMD stock for Q4 2025, down 53% quarter-over-quarter.
- 20 funds opened new LifeMD positions in Q4 2025 and 30 closed out, a net change of -10 holders.
- The largest LifeMD buyer in Q4 2025 was Federated Hermes, an estimated $3.5M added.
- The largest LifeMD seller in Q4 2025 was Nuveen, an estimated $5.94M sold.
Based on aggregated 13F filings for Q4 2025.